Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastrointest Oncol. Jan 15, 2018; 10(1): 31-39
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.31
Table 5 Relationship between adjuvant treatment and the prognosis of T4bN1-3M0/TxN3bM0 gastric cancer patients
TreatmentnMedian DFS (mo)3-yr DFS (%)P valueMedianOS (mo)5-yr OS (%)P value
Adjuvant chemotherapyYes16412.310.4%0.00025.716.1%0.532
No122.80.0%18.722.2%
ChemotherapyMono- therapy106.70.0%0.58320.30.0%0.661
RegimenDoublet13412.05.3%26.317.4%
Triple2013.05.3%29.718.5%
Adjuvant chemotherapy time≥ 6 mo3923.220.2%0.00040.225.0%0.001
< 6 mo1259.97.3%21.613.4%